InnoSlim® supports metabolic wellness by helping the body use fat for energy when combined with a healthy diet and exercise.



  • Supports metabolic wellness in studied human subjects*


InnoSlim® has demonstrated in NuLiv Science preclinical and human studies to have promising effects on metabolic health and function in tested subjects. These studies suggest that InnoSlim® could achieve this by activating a specific pathway called the adiponectin and AMPK signaling pathway.


This pathway helps determine the utilization of energy sources in the body, including signaling when to use fat for energy instead of relying on consumed sugars. This pathway is an important part of broader metabolic health and energy balance in the body.


In this way, InnoSlim® works to activate a pathway in your muscles that helps break down fats and take in sugar for energy. This has been observed in both preclinical and human studies conducted by NuLiv Science.1, 2, 3  The results suggest that InnoSlim® may support overall metabolic wellness and maintaining a healthy weight, as shown by specific markers in human trials.4, 5


Fat Burners, Intra-Workout Formulas


RTDs, Powdered Drink Mixes, Breakfast Shake Formulas, Bars, Baked Goods, Gummies, and Gels


Vitamins and Minerals

Highly purified fractions extracted from NLF-03 Astragalus membranaceus (root)

and Panax notoginseng (root).


Clinical Dosage: 250mg

1. Y.C. Huang, etc. Effect and mechanism of ginsenosides CK and Rg1 on stimulation of glucose uptake in 3T3-L1 adipocytes. Journal of Agricultural Food Chemistry. 2010, 58, 6039–6047.


2. W.L. Chang, etc. The inhibitory effect of ginsenoside Rg1 on glucose and lipid production in human HepG2 cells. Adaptive Medicine. 2013, 5(4):181-188.


3. C.W. Wang, etc. An essential role of cAMP response element binding protein in ginsenoside Rg1-mediated inhibition of Na1/glucose cotransporter 1 gene expression. Molecular Pharmacology.2015, 88(6):1072-83.


4. S.C. Huang, etc. Radix Astragali and Notoginseng saponins improve glucose and fatty acid metabolism through upregulated adiponectin and its downstream signaling. J of Biochemistry and Biotechnology, August 2021.


5. S.C. Huang, etc. Anti-hyperglycemic and anti-hyperlipidemic activities of Radix Astragali and Panax notoginseng extract in human participants: A randomized, double-blind, crossover clinical trial. J. of Biochemistry and Biotechnology, June 2022.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.